It is estimated that about 20% to 40% of patients with atrial fibrillation have concomitant coronary artery disease (CAD), a sizable proportion of which require revascularization with percutaneous coronary intervention (PCI). and stenting. Such patients require dual antiplatelet therapy (DAPT) to prevent the risk of stent thrombosis and additional thrombotic ischemic events. Read more to understand more about anticoagulation in atrial fibrillation after percutaneous coronary intervention.